- Home
- GLU vs ANIX Comparison
GLU vs ANIX Comparison
Compare GLU & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLU
- ANIX
- Stock Information
- Founded
- GLU 2004
- ANIX 1982
- Country
- GLU United States
- ANIX United States
- Employees
- GLU N/A
- ANIX N/A
- Industry
- GLU Finance/Investors Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- GLU Finance
- ANIX Health Care
- Exchange
- GLU Nasdaq
- ANIX Nasdaq
- Market Cap
- GLU 92.2M
- ANIX 82.7M
- IPO Year
- GLU N/A
- ANIX 1987
- Fundamental
- Price
- GLU $15.56
- ANIX $3.11
- Analyst Decision
- GLU
- ANIX Strong Buy
- Analyst Count
- GLU 0
- ANIX 2
- Target Price
- GLU N/A
- ANIX $8.50
- AVG Volume (30 Days)
- GLU 12.4K
- ANIX 136.7K
- Earning Date
- GLU 01-01-0001
- ANIX 03-11-2025
- Dividend Yield
- GLU 8.60%
- ANIX N/A
- EPS Growth
- GLU N/A
- ANIX N/A
- EPS
- GLU 0.62
- ANIX N/A
- Revenue
- GLU N/A
- ANIX N/A
- Revenue This Year
- GLU N/A
- ANIX N/A
- Revenue Next Year
- GLU N/A
- ANIX N/A
- P/E Ratio
- GLU $22.50
- ANIX N/A
- Revenue Growth
- GLU N/A
- ANIX N/A
- 52 Week Low
- GLU $11.61
- ANIX $2.07
- 52 Week High
- GLU $15.40
- ANIX $4.67
- Technical
- Relative Strength Index (RSI)
- GLU 57.11
- ANIX 64.69
- Support Level
- GLU $15.40
- ANIX $2.89
- Resistance Level
- GLU $15.68
- ANIX $3.05
- Average True Range (ATR)
- GLU 0.31
- ANIX 0.20
- MACD
- GLU 0.10
- ANIX 0.06
- Stochastic Oscillator
- GLU 86.79
- ANIX 94.32
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.